Fifteen Students Living With IBD Receive Scholarships to Help Pursue Their Education

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Fifteen Students Living With IBD Receive Scholarships to Help Pursue Their EducationAuthor of the article:The AbbVie IBD Scholarship Program marks 15 years of recognizing the resilience and ambitions of students across Canada living with Crohn’s disease or ulcerative colitisTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountTORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) — Crohn’s and Colitis Canada and AbbVie Canada are proud to announce the 2026 recipients of the AbbVie IBD Scholarship Program. Fifteen students from across Canada will each receive a $5,000 scholarship to support their postsecondary education while living with Crohn’s disease or ulcerative colitis.This year also marks 15 years of the AbbVie IBD Scholarship Program. Since its launch in 2012, the program has now supported 184 students across Canada with $920,000 in scholarships.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try again“Students living with Crohn’s or colitis are working toward the same goals as their peers, but their disease can demand time, energy and attention that other students are free to put elsewhere,” said Josh Berman, President and CEO of Crohn’s and Colitis Canada. “The AbbVie IBD Scholarship recognizes that added burden, but more importantly, it celebrates what these students are accomplishing. By easing some of the financial pressure of postsecondary education, we can give recipients more room to focus on their studies, their communities and the futures they are building. We are incredibly proud of this year’s recipients and grateful to AbbVie for 15 years of commitment to students living with IBD.”Living with IBD can affect very practical parts of the student experience. A recent national survey conducted by Crohn’s and Colitis Canada confirmed that three in four respondents said they are always adapting their lifestyle around the disease. For students, a flare can mean missing class, and fatigue can make it harder to study or participate in campus life. An urgent need for a washroom can shape how someone plans their day. And because many of these challenges are not visible, students may also find themselves navigating a disease that instructors or peers are not aware of or do not fully understand. The AbbVie IBD Scholarship helps ease some of the financial pressure of postsecondary education, giving recipients more space to focus on their education, their health, and the futures they are working to build.“Postsecondary education is a time of growth, independence and possibility. For students living with IBD, it also means managing the physical, emotional and social challenges of a chronic disease during some of the most important years of their lives,” said Tanu Misra, vice-president and general manager, AbbVie Canada. “As we mark 15 years of the AbbVie IBD Scholarship Program, we are honoured, alongside Crohn’s and Colitis Canada, to recognize students whose determination and resilience continue to inspire us. Their achievements are a powerful reminder that IBD does not define what is possible for their future.”2026 AbbVie IBD Scholarship recipients Autumn Beemer, British Columbia — University of Alberta Clinton Shard Memorial Scholarship recipient Aya Chapanian, British Columbia — Queen’s UniversityMya Chàvez-Bourget, Quebec — Université de SherbrookeThunder Crowshoe, Alberta — University of LethbridgeEdden Gitelman, Quebec — Université de MontréalCourtney Kates, Ontario — York UniversityOlivia LeBlanc, Nova Scotia — Dalhousie UniversityHannah MacDonald, New Brunswick — Dalhousie UniversityJulia Rutenberg, Ontario — Wilfrid Laurier UniversityMadison (Mady) Saby, Alberta — University of CalgaryBethany Suen, Ontario — University of TorontoGayashan Tennakoon, Ontario — University of TorontoAlexis Tremblay, Quebec — Université de SherbrookeJonas Wong, Alberta — University of AlbertaEthan Zahn, Ontario — Brock UniversityThis advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.To learn more about the 2026 AbbVie IBD Scholarship recipients, visit crohnsandcolitis.ca/recipients.More than 322,000 Canadians currently live with Crohn’s disease or ulcerative colitis, with that number expected to rise to 470,000 by 2035. These conditions can develop at any age, though they most commonly appear in early adulthood, between the ages of 20 and 29. Alarmingly, new diagnoses are increasing most rapidly among children under the age of six.Crohn’s and colitis cause the immune system to attack healthy tissue in the gastrointestinal tract, leading to inflammation. Common symptoms include severe abdominal pain, nausea, fatigue, internal bleeding, and an urgent, unpredictable need to use the washroom.About the AbbVie IBD Scholarship ProgramCrohn’s and Colitis Canada partnered with AbbVie Canada in 2012 to launch the AbbVie IBD Scholarship Program to support students living with Crohn’s disease or ulcerative colitis as they pursue their academic goals and make a meaningful difference in their communities.Each year, 15 students receive a $5,000 scholarship toward their postsecondary education.About Crohn’s and Colitis CanadaCrohn’s and Colitis Canada is on a relentless journey to cure Crohn’s disease and ulcerative colitis and improve the quality of life of everyone affected by these diseases.Through research funding, advocacy, education and patient programs, the organization advances care and support for people living with IBD. Learn more at crohnsandcolitis.ca. Follow @getgutsycanada on Facebook and Instagram, and at Crohn’s and Colitis Canada on YouTube and LinkedIn.AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas including immunology, oncology and neuroscience – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.ca. Follow AbbVie in Canada on LinkedIn,Instagram, and YouTube.For media queries, Please write to us at media@crohnsandcolitis.caNotice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.